| Id |
Subject |
Object |
Predicate |
Lexical cue |
| 11862422-13#0#4#gene387882 |
2060-2064 |
gene387882 |
denotes |
OCC1 |
| 11862422-13#0#4#gene11167 |
2060-2064 |
gene11167 |
denotes |
OCC1 |
| 11862422-22#61#65#gene387882 |
2772-2776 |
gene387882 |
denotes |
OCC1 |
| 11862422-22#61#65#gene11167 |
2772-2776 |
gene11167 |
denotes |
OCC1 |
| 11862422-22#71#88#diseaseC0029925 |
2782-2799 |
diseaseC0029925 |
denotes |
ovarian carcinoma |
| 11862422-22#71#88#diseaseC0677886 |
2782-2799 |
diseaseC0677886 |
denotes |
ovarian carcinoma |
| 11862422-22#71#88#diseaseC0029925 |
2782-2799 |
diseaseC0029925 |
denotes |
ovarian carcinoma |
| 11862422-22#71#88#diseaseC0677886 |
2782-2799 |
diseaseC0677886 |
denotes |
ovarian carcinoma |
| 11862422-13#81#97#diseaseC0000735 |
2836-3166 |
diseaseC0000735 |
denotes |
and carboplatin treatment.
CONCLUSION: The SEAP marker protein is constitutively expressed by tumor cells and blood levels are correlated with tumor cell number and burden. The results of these studies indicate that SEAP may be used as an in vivo reporter gene in a mouse model to monitor tumor growth and response to therapeutics |
| 0#4#gene1116781#97#diseaseC0000735 |
11862422-13#0#4#gene11167 |
11862422-13#81#97#diseaseC0000735 |
associated_with |
OCC1,"and carboplatin treatment.
CONCLUSION: The SEAP marker protein is constitutively expressed by tumor cells and blood levels are correlated with tumor cell number and burden. The results of these studies indicate that SEAP may be used as an in vivo reporter gene in a mouse model to monitor tumor growth and response to therapeutics" |
| 0#4#gene38788281#97#diseaseC0000735 |
11862422-13#0#4#gene387882 |
11862422-13#81#97#diseaseC0000735 |
associated_with |
OCC1,"and carboplatin treatment.
CONCLUSION: The SEAP marker protein is constitutively expressed by tumor cells and blood levels are correlated with tumor cell number and burden. The results of these studies indicate that SEAP may be used as an in vivo reporter gene in a mouse model to monitor tumor growth and response to therapeutics" |
| 61#65#gene1116771#88#diseaseC0029925 |
11862422-22#61#65#gene11167 |
11862422-22#71#88#diseaseC0029925 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene1116771#88#diseaseC0029925 |
11862422-22#61#65#gene11167 |
11862422-22#71#88#diseaseC0029925 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene1116771#88#diseaseC0677886 |
11862422-22#61#65#gene11167 |
11862422-22#71#88#diseaseC0677886 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene1116771#88#diseaseC0677886 |
11862422-22#61#65#gene11167 |
11862422-22#71#88#diseaseC0677886 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene38788271#88#diseaseC0029925 |
11862422-22#61#65#gene387882 |
11862422-22#71#88#diseaseC0029925 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene38788271#88#diseaseC0029925 |
11862422-22#61#65#gene387882 |
11862422-22#71#88#diseaseC0029925 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene38788271#88#diseaseC0677886 |
11862422-22#61#65#gene387882 |
11862422-22#71#88#diseaseC0677886 |
associated_with |
OCC1,ovarian carcinoma |
| 61#65#gene38788271#88#diseaseC0677886 |
11862422-22#61#65#gene387882 |
11862422-22#71#88#diseaseC0677886 |
associated_with |
OCC1,ovarian carcinoma |
